PeptideAnswerPeptideAnswerAsk a question
Anti-Aging & Longevity

HGH 191AA

Also called somatropin, human growth hormone, recombinant hGH

This is actual human growth hormone - the full 191-amino-acid protein, identical to what your pituitary makes.

Where this answer comes fromApproved medicine

This one has been through full clinical trials and is an approved medicine somewhere in the world. The ranges below are drawn from those trials and from what the community reports using.

The quick answer

This is actual human growth hormone - the full 191-amino-acid protein, identical to what your pituitary makes. Everything else in this family asks your body to release its own supply. This one supplies it.

What it is not

Not a peptide releaser and not comparable to one. Different risk, different result, different price.

Why people use it

💪 Clearly the strongest effect on body composition in this family; 🩹 Recovery and skin quality; 😴 Sleep; 🏥 Decades of human clinical data behind it

What people report using

These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.

People report running this anywhere from 1IU to 2IU, daily, 5–6 days a week.Where somebody sits in that range depends on what they are using it for and what they are starting from — the low end is a deliberate choice a lot of people make, not a half-hearted version of the high end.

Conservative — 1–2 IU daily1–2IU

Recovery & anti-aging

How often
Daily, 5–6 days a week
Route
subcutaneous
Where this comes from
Approved medicine

Sleep and skin early; body composition over three to six months.

What to expect, and when

Week 1-3: sleep and skin. Week 4-8: recovery; water and hand stiffness if the dose is too high. Month 3-6: body composition, which is where the real effect shows.

Side effects, and what people do about them

Fluid retention and carpal-tunnel-type numbness are the most reported, and both track with dose. Joint aches early on. Insulin resistance with sustained higher exposure is the one the community takes seriously. These reports rise sharply with dose and duration and are described as settling on stopping.

Go deeper

Open these only if you want them.

How it actually works

Recombinant somatropin. Acts directly at growth hormone receptors and drives IGF-1 production in the liver. There is no feedback loop in play - your body's own brake does not apply - and that is the entire difference between this and the releasers.

More on the evidence

An approved prescription drug with decades of trial data. Prescription-only in Canada.

What people report, in full

Growth hormone is discussed differently from everything else here, and the community is unusually consistent about why: it works, and the trade-offs are real and dose-dependent. The strongest and most repeated advice is that low and long beats high and short - the people reporting problems are almost always the ones who went high. Carpal-tunnel symptoms and stiff hands in the morning are read as the classic early sign of too much, and the standard response is to come down rather than push through. Sleep and skin are the earliest positives; body composition is described in months rather than weeks. Blood glucose comes up constantly as the thing to actually watch, and long-run users treat periodic bloodwork as ordinary rather than cautious. The releasers get compared to it endlessly, and the honest community verdict is that they are not in the same weight class - which cuts both ways.

Worth knowing

The human testing was for a different purpose than people use it for here

The trials are real. They were not asking the question most people are asking when they come looking for this one.

The case against

Approved and studied for decades in growth hormone deficiency, in children and adults. Its use by healthy adults for composition or longevity is not the question those trials asked.

Sources and review

What people report

This record is built on what the wider community reports doing and experiencing, summarised above. No counted dataset has been attached to this compound yet — when one is published, it goes here with its numbers.

References

Growth hormone replacement therapy in adult-onset GH deficiency: effects on body composition, a double-blind randomized placebo-controlled trial. J Clin Endocrinol Metab 2004;89(5):2048. PMID 15126520.

Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15,809 GH-Treated Patients. J Clin Endocrinol Metab 2022;107(7):1906.

These references were located by literature search and recorded as the primary sources behind this record. The publishers block automated retrieval, so they are pointers to the right papers rather than quotations we have checked line by line. They are replaced as we read them properly.

Last reviewed 2026-09-08.

People also look at